{"id":17122,"date":"2023-05-03T09:44:07","date_gmt":"2023-05-03T07:44:07","guid":{"rendered":"https:\/\/www.pharmaforum.be\/news\/penuries-de-medicaments-en-europe-il-faut-du-temps\/"},"modified":"2023-07-11T14:56:46","modified_gmt":"2023-07-11T12:56:46","slug":"penuries-de-medicaments-en-europe-il-faut-du-temps","status":"publish","type":"news","link":"https:\/\/www.pharmaforum.be\/fr\/news\/penuries-de-medicaments-en-europe-il-faut-du-temps\/","title":{"rendered":"P\u00e9nuries de m\u00e9dicaments en Europe: il faut du temps.."},"content":{"rendered":"<p>Depuis la fin de l&#8217;ann\u00e9e 2022, les pays de l&#8217;Union europ\u00e9enne font \u00e9tat de graves difficult\u00e9s d&#8217;approvisionnement en certains m\u00e9dicaments cl\u00e9s, une majorit\u00e9 d&#8217;entre eux connaissant aujourd&#8217;hui des p\u00e9nuries effectives.<br \/>\nDans une enqu\u00eate sur les p\u00e9nuries de m\u00e9dicaments men\u00e9e par le groupe pharmaceutique de l&#8217;Union europ\u00e9enne (UE) entre le 14 novembre et le 31 d\u00e9cembre 2022, 100 % des 29 \u00c9tats membres ont signal\u00e9 des p\u00e9nuries de m\u00e9dicaments chez les pharmaciens et 76 % ont d\u00e9clar\u00e9 que les p\u00e9nuries \u00e9taient pires que l&#8217;ann\u00e9e pr\u00e9c\u00e9dente, en 2021.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pour la quatri\u00e8me ann\u00e9e cons\u00e9cutive, les p\u00e9nuries de m\u00e9dicaments sont le principal d\u00e9fi auquel sont confront\u00e9es les pharmacies &#8211; des statistiques stup\u00e9fiantes!<\/p>\n","protected":false},"featured_media":17132,"template":"","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_api_id":"46728","_exhibitors":["16738"],"footnotes":""},"edition":[451],"country":[],"class_list":["post-17122","news","type-news","status-publish","has-post-thumbnail","hentry","edition-pharma-forum-2023"],"_links":{"self":[{"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/news\/17122","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/types\/news"}],"version-history":[{"count":2,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/news\/17122\/revisions"}],"predecessor-version":[{"id":17131,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/news\/17122\/revisions\/17131"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/media\/17132"}],"wp:attachment":[{"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/media?parent=17122"}],"wp:term":[{"taxonomy":"edition","embeddable":true,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/edition?post=17122"},{"taxonomy":"country","embeddable":true,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/country?post=17122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}